Stockscreener 앱 받기
3.10
6.34%
-0.21
Eledon Pharmaceuticals Inc 주식(ELDN)의 최신 뉴스
Eledon Pharmaceuticals Inc expected to post a loss of 30 cents a shareEarnings Preview - TradingView
Eledon: A Company With Good Early Data In Kidney Transplant Rejection And A Full Balance Sheet - Seeking Alpha
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) has caught the attention of institutional investors who hold a sizeable 46% stake - Yahoo Finance
Geode Capital Management LLC Buys 285,043 Shares of Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Eledon Pharmaceuticals appoints Deloitte as new auditor By Investing.com - Investing.com Nigeria
Eledon Pharmaceuticals appoints Deloitte as new auditor - Investing.com
Charles Schwab Investment Management Inc. Purchases 15,000 Shares of Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) - Defense World
Virtu Financial LLC Takes $82,000 Position in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) - Defense World
Is Eledon Pharmaceuticals (ELDN) The Hot Biotech Stock Under $5? - Yahoo
Equities Analysts Set Expectations for ELDN FY2025 Earnings - Defense World
Research Analysts Set Expectations for ELDN FY2025 Earnings - Defense World
What is Leerink Partnrs’ Forecast for ELDN Q1 Earnings? - Defense World
Eledon Pharmaceuticals Reports 2024 Financial Results and Clinical Advances - MSN
We're Hopeful That Eledon Pharmaceuticals (NASDAQ:ELDN) Will Use Its Cash Wisely - Yahoo
10 Hot Biotech Stocks Under $5 - Insider Monkey
Eledon Pharmaceuticals, Inc. SEC 10-K Report - TradingView
Eledon Pharmaceuticals Inc. (ELDN) reports earnings - Quartz
Eledon Pharmaceuticals FY Operating Expenses USD 70.577 Million -March 20, 2025 at 04:48 pm EDT - Marketscreener.com
Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Operating and Financial Results - The Manila Times
Eledon Achieves Historic Transplant Milestones as Cash Position Hits $140M - StockTitan
Eledon Pharmaceuticals (ELDN) to Release Earnings on Thursday - Defense World
Institutional investors in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) see US$25m decrease in market cap last week, although long-term gains have benefitted them. - Simply Wall St
Eledon Pharmaceuticals to Participate in Leerink Partners Global Healthcare Conference - GlobeNewswire
When Can You Hear Eledon's Latest Strategic Updates? Key Conference Appearance Scheduled - StockTitan
Eledon Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire
Eledon Touts Tegoprubart Used in Pig Kidney Transplant - Orange County Business Journal
Before You Invest, Make Sure You Check This Eledon Pharmaceuticals Inc (NASDAQ: ELDN) Analysis - Stocks Register
Leerink Partnrs Has Pessimistic Outlook of ELDN Q4 Earnings - MarketBeat
Leerink Partnrs Issues Pessimistic Outlook for ELDN Earnings - Armenian Reporter
Eledon's tegoprubart used in second pig-to-human kidney transplant - MSN
Leerink Partnrs Issues Negative Outlook for ELDN Earnings - Defense World
Eledon's tegoprubart used in second pig-to-human kidney transplant By Investing.com - Investing.com South Africa
Eledon Pharmaceuticals Announces Use of Tegoprubart as Key - GlobeNewswire
Eledon announces tegoprubart use in transplant of pig kidney into human - TipRanks
Revolutionary Xenotransplant Success: Eledon Drug Enables Patient Freedom from Dialysis - StockTitan
FY2029 Earnings Estimate for ELDN Issued By Leerink Partnrs - Armenian Reporter
Eledon Pharmaceuticals (NASDAQ:ELDN) Coverage Initiated by Analysts at Guggenheim - MarketBeat
Eledon Pharmaceuticals to Participate in Guggenheim Securities SMID Cap Biotech Conference - The Manila Times
Eledon CEO to Reveal Latest Biotech Developments at Major Guggenheim Conference - StockTitan
Eledon Pharmaceuticals: At The Forefront Of The Organ Transplant Management Business - Seeking Alpha
Guggenheim Initiates Eledon Pharmaceuticals at Buy With $9 Price Target -January 28, 2025 at 07:34 am EST - Marketscreener.com
Inspire Investing LLC Invests $802,000 in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) - MarketBeat
0.39%
3.66%
자본화:
|
볼륨(24시간):